• ML365: Advancing TASK1 Inhibitor Use in Neurophysiology Rese

  2026-08-06

  ML365 (2-methoxy-N-(3-(3-methylbenzamido)phenyl)benzamide) enables high-precision inhibition of TASK1 channels, unlocking rigorous target validation and mechanistic studies in neuroinflammation and cognitive impairment models. Its cross-platform potency and selectivity position ML365 as an indispensable neurophysiology research tool for dissecting potassium channel function and inflammasome signaling.

• Bufalin-CRISPR Nanomedicine Reprograms Immunity in Colorecta

  2026-08-05

  A recent study introduces a calcium lactate nanoparticle delivery system that co-encapsulates bufalin and CRISPR/Cas9 to induce pyroptosis and immune reprogramming in colorectal cancer. This multimodal approach targets both tumor cells and the immunosuppressive microenvironment, offering new avenues for overcoming resistance in immunotherapy.

• Rhodamine B: Optimizing Fluorescent Probe Use in Cell Labeli

  2026-08-05

  Rhodamine B (Basic Violet 10) offers outstanding solubility and signal amplification for fluorescence-based assays across cellular and environmental research. This article delivers applied workflows, troubleshooting guidance, and the latest innovations, empowering reproducible and high-sensitivity cell labeling and microscopy.

• Miltefosine: Dual-Pathway Regulation and Immune Recovery Unv

  2026-08-04

  Explore how Miltefosine, a PI3K/Akt pathway inhibitor and Ras/MEK/ERK activator, uniquely modulates immune cell fate and bone marrow recovery. This article delivers a fresh, mechanistic perspective and actionable guidance beyond standard protocol summaries.

• PYR-41: Selective Inhibitor of Ubiquitin-Activating Enzyme E

  2026-08-04

  PYR-41 is a well-characterized, small molecule inhibitor of the Ubiquitin-Activating Enzyme E1. It blocks ubiquitination and proteasomal degradation, providing a precise tool for dissecting protein homeostasis and inflammation pathways. Quantitative effects are demonstrated both in vitro and in vivo, supporting its use in advanced research models.

• PD0325901 MEK Inhibitor: Optimizing Cancer and Stem Cell Wor

  2026-08-03

  PD0325901 stands out as a highly selective MEK inhibitor, empowering researchers to dissect the RAS/RAF/MEK/ERK pathway in oncology and stem cell contexts. This article distills advanced protocol guidance, real-world troubleshooting, and key insights from recent breakthroughs to maximize reproducibility and biological insight in your experiments.

• Afatinib (BIBW 2992): Precision Inhibition in Tumor Microenv

  2026-08-03

  Explore how Afatinib (BIBW 2992) enables high-resolution dissection of ErbB signaling and drug resistance dynamics within physiologically relevant gastric cancer assembloid models. This comprehensive review reveals unique insights for advanced targeted therapy research.

• Catalpol as a Multi-Target EphA2/FAK/Src Pathway Inhibitor i

  2026-08-02

  Explore Catalpol’s unique anti-fibrotic mechanism as an EphA2/FAK/Src pathway inhibitor. This in-depth analysis uncovers its translational value for liver fibrosis and practical guidance for advanced research models.

• Propranolol: Non-Selective β-Adrenergic Blocker in Research

  2026-08-01

  Propranolol’s dual β1/β2 antagonism enables refined cardiovascular and neurobehavioral research, bridging bench protocols with clinical relevance. This guide unpacks robust workflows, troubleshooting strategies, and actionable insights to help researchers maximize experimental reliability using APExBIO’s Propranolol.

• Baicalein: Applied Workflows for Cancer and Inflammation Res

  2026-07-31

  Baicalein (5,6,7-trihydroxy-2-phenylchromen-4-one) is a high-purity flavonoid unlocking advanced cancer and inflammation assays by targeting the 12-LOX pathway. This guide delivers hands-on protocols, troubleshooting insights, and actionable data for translational researchers seeking robust inhibition of arachidonic acid metabolism and apoptosis pathway analysis.

• NSC-23766: Optimizing Rac GTPase Inhibition in Cancer Resear

  2026-07-31

  Unlock precision control over Rac1-driven pathways with NSC-23766, a Rac GTPase inhibitor trusted for dissecting cell migration, apoptosis, and stemness in cancer models. Discover advanced protocol enhancements, troubleshooting tips, and insights from the latest reference study to drive reproducible, high-impact results.

• a-MSH, amide: Precision Tools for Pigmentation Regulation Re

  2026-07-30

  a-MSH, amide from APExBIO empowers researchers to dissect melanogenesis and inflammation with superior reproducibility, enabling robust workflows for studying pigmentation disorders. Its defined mechanism and customizable protocol parameters drive innovation in both basic and translational pigmentation regulation research.

• Refining In Vitro Drug Response Evaluation in Cancer Researc

  2026-07-30

  Schwartz's dissertation critically advances how in vitro assays distinguish between cancer cell proliferation arrest and cell death, revealing that most anti-cancer agents—including novel PARP inhibitors—exert complex, temporally distinct effects on both processes. This nuanced framework enhances experimental controls and informs the interpretation of drug efficacy data, particularly relevant for agents targeting DNA repair in breast cancer and BRCA1-mutated models.

• Adiponectin Mitigates PND via TLR4/NF-κB Suppression in Aged

  2026-07-29

  This study demonstrates that adiponectin administration alleviates cognitive deficits induced by splenectomy in aged rats by reducing neuroinflammation and oxidative stress through inhibition of the TLR4/MyD88/NF-κB pathway. These findings clarify mechanistic links in perioperative neurocognitive disorder and suggest targeted strategies for intervention.

• O6-Benzylguanine: Precision MGMT Inhibition for DNA Repair R

  2026-07-29

  Explore how O6-Benzylguanine, a potent MGMT inhibitor, enables advanced DNA repair inhibition and cancer chemotherapy research. This deep-dive unpacks recent mechanistic findings and practical workflow decisions, setting a new benchmark for translational assay design.

453 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page